The role of osteogenic cells in the pathophysiology of Paget's disease

Journal of Bone and Mineral Research

Volumn 14, Issue SUPPL. 2, 1999, Pages 9-16

  Robey, Pamela Gehron ^a,d   Bianco, Paolo ^b,c  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

^d MSC 4320 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOCRINE EFFECT; BONE MARROW; BONE MATRIX; CELL INTERACTION; CONFERENCE PAPER; EXPERIMENTAL MODEL; HISTOPATHOLOGY; HUMAN; MALIGNANT TRANSFORMATION; OSTEOBLAST; OSTEOSARCOMA; PAGET BONE DISEASE; PARACRINE SIGNALING; PATHOGENESIS; PATHOPHYSIOLOGY; TUMOR SUPPRESSOR GENE;

EID: 0032884116     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.5650140204     Document Type: Conference Paper

References (64)

1. Paget J 1877 On a form of chronic inflammation of bones. Med Chir Tr 60:37.
2. Rebel A, Basle M, Pouplard A, Malkani K, Filmon R, Lepatezour A 1980 Bone tissue in Paget's disease of bone. Ultrastructure immunocytology. Arthritis Rheum 23:1104-1114.
3. Fornasier VL, Flores L, Hastings D, Sharp T 1985 Virus-like filamentous intranuclear inclusions in a giant-cell tumor, not associated with Paget's disease of bone. A case report. J Bone Joint Surg [Am] 67:333-336.
4. Schajowicz F, Ubios AM, Araujo ES, Cabrini RL 1985 Virus-like intranuclear inclusions in giant cell tumor of bone. Clin Orthop 201:247-250.
5. Beneton MN, Harris S, Kanis JA 1987 Paramyxovirus-like inclusions in two cases of pycnodysostosis. Bone 8:211-217.
6. Bianco P, Silvestrini G, Ballanti P, Bonucci E 1992 Paramyxovirus-like nuclear inclusions identical to those of Paget's disease of bone detected in giant cells of primary oxalosis. Virchows Arch a Pathol Anat Histopathol 421:427-433.
7. Basle MF, Fournier JG, Rozenblatt S, Rebel A, Bouteille M 1986 Measles virus RNA detected in Paget's disease bone tissue by in situ hybridization. J Gen Virol 67:907-913.
8. Mills BG, Singer FR 1987 Critical evaluation of viral antigen data in Paget's disease of bone. Clin Orthop 217:16-25.
9. Gordon MT, Anderson DC, Sharpe PT 1991 Canine distemper virus localised in bone cells of patients with Paget's disease. Bone 12:195-201.
10. Gordon MT, Mee AP, Anderson DC, Sharpe PT 1992 Canine distemper virus transcripts sequenced from pagetic bone [see comments]. Bone Miner 19:159-174.
11. Ralston SH, Digiovine FS, Gallacher SJ, Boyle IT, Duff GW 1991 Failure to detect paramyxovirus sequences in Paget's disease of bone using the polymerase chain reaction. J Bone Miner Res 6:1243-1248.
12. Birch MA, Taylor W, Fraser WD, Ralston SH, Hart CA, Gallagher JA 1994 Absence of paramyxovirus RNA in cultures of pagetic bone cells and in pagetic bone. J Bone Miner Res 9:11-16.
13. Siris ES 1998 Paget's disease of bone. J Bone Miner Res 13:1061-1065.
14. Rodan GA 1998 Mechanisms of action of bisphosphonates. Annu Rev Pharmacol Toxicol 38:375-388.
15. Roodman GD 1996 Advances in bone biology: The osteoclast. Endocr Rev 17:308-332.
16. Kahn AJ 1990 The viral etiology of Paget's disease of bone: A new perspective. Calcif Tissue Int 47:127-129.
17. Suda T, Udagawa N, Takahashi N 1996 Cells of bone: Osteoclast generation. In: Bilezikian JP, Raisz LG, Rodan GA (eds.) The Principles of Bone Biology. Academic Press, New York, pp. 87-102.
18. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T 1998 Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:3597-3602.
19. Mills BG, Singer FR, Weiner LP, Holst PA 1980 Cell cultures from bone affected by Paget's disease. Arthritis Rheum 23:1115-1120.
20. Cartwright EJ, Gordon MT, Freemont AJ, Anderson DC, Sharpe PT 1993 Paramyxoviruses and Paget's disease. J Med Virol 40:133-141.
21. Basle MF, Rebel A, Fournier JG, Russell WC, Malkani K 1987 On the trail of paramyxoviruses in Paget's disease of bone. Clin Orthop 217:9-15.
22. Jaffe HL 1972 Metabolic degenerative and inflammatory diseases of bones and joints. Urban and Schwarzenberg, Berlin.
23. Renier JC, Leroy E, Audran M 1996 The initial site of bone lesions in Paget's disease. A review of two hundred cases. Rev Rhum Engl Ed 63:823-829.
24. Bianco P, Riminucci M 1998 The bone marrow stroma in vivo: Ontogeny, structure, cellular composition and changes in disease. In: Beresford JN, Owen ME (eds.) Marrow Stromal Cell Culture. Cambridge University Press, Cambridge, U.K., pp. 10-25.
25. Bianco P, Bonucci E 1991 Endosteal surfaces in hyperparathyroidism: An enzyme cytochemical study on low-temperature-processed, glycol-methacrylate-embedded bone biopsies. Virchows Arch a Pathol Anat Histopathol 419:425-431.
26. Bianco P, Boyde A 1993 Confocal images of marrow stromal (Westen-Bainton) cells. Histochemistry 100:93-99.
27. Riminucci M, Fisher LW, Shenker A, Spiegel AM, Bianco P, Gehron Robey P 1997 Fibrous dysplasia of bone in the McCune-Albright syndrome: abnormalities in bone formation. Am J Pathol 151:1587-1600,
28. Meunier PJ, Coindre JM, Edouard CM, Arlot ME 1980 Bone histomorphometry in Paget's disease. Quantitative and dynamic analysis of pagetic and nonpagetic bone tissue. Arthritis Rheum 23:1095-1103.
29. Schmorl G 1932 Uber Osteitis Deformans Paget. Virchows Arch Pathol Anat 283:694-732.
30. Fornasier VL 1977 Osteoid: An ultrastructural study. Hum Pathol 8:243-254.
31. Garnero P, Fledelius C, Gineyts E, Serre CM, Vignot E, Delmas PD 1997 Decreased beta-isomerization of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget's disease of bone. J Bone Miner Res 12:1407-1415.
32. Gehron Robey P, Boskey AL 1996 The biochemistry of bone. In: Marcus R, Feldman D (eds.) Osteoporosis. Raven Press, New York, NY, U.S.A., pp. 95-184.
33. Ingram RT, Collazo-Clavell M, Tiegs R, Fitzpatrick LA 1996 Paget's disease is associated with changes in the immunohistochemical distribution of noncollagenous matrix proteins in bone. J Clin Endocrinol Metab 81:1810-1820.
34. Hankey DP, Hughes AE, Mollan RA, Nicholas RM 1993 Extracellular protein secretion of cultured normal and pagetic osteoblasts. Electrophoresis 14:644-649.
35. Diaz Diego EM, Nacher M, Rapado A, Serrano S, Bosch J, Aubia J, de la Piedra C 1998 Immunoreactive osteocalcin forms in conditioned media from human osteoblast culture and in sera from healthy adult control subjects and patients with bone pathologies. Eur J Clin Invest 28:48-58.
36. Tarquini R, Perfetto F, Tarquini B 1998 Endothelin-1 and Paget's bone disease: Is there a link? Calcif Tissue Int 63:118-120.
37. Birch MA, Ginty AF, Walsh CA, Fraser WD, Gallagher JA, Bilbe G 1993 PCR detection of cytokines in normal human and pagetic osteoblast-like cells. J Bone Miner Res 8:1155-1162.
38. de Vernejoul MC, Cohen-Solal M, Orcel P 1993 Bone cytokines. Curr Opin Rheumatol 5:332-338.
39. Mills BG, Frausto A 1997 Cytokines expressed in multinucleated cells: Paget's disease and giant cell tumors versus normal bone. Calcif Tissue Int 61:16-21.
40. Mundy GR 1992 Cytokines and local factors which affect osteoclast function. Int J Cell Cloning 10:215-222.
41. Ralston SH, Hoey SA, Gallacher SJ, Adamson BB, Boyle IT 1994 Cytokine and growth factor expression in Paget's disease: Analysis by reverse-transcription/polymerase chain reaction. Br J Rheumatol 33:620-625.
42. O'Keefe RJ, Teot LA, Singh D, Puzas JE, Rosier RN, Hicks DG 1997 Osteoclasts constitutively express regulators of bone resorption: An immunohistochemical and in situ hybridization study. Lab Invest 76:457-465.
43. Hoyland JA, Freemont AJ, Sharpe PT 1994 Interleukin-6, IL-6 receptor, and IL-6 nuclear factor gene expression in Paget's disease. J Bone Miner Res 9:75-80.
44. Gehron Robey P, Bianco P 1999 Cellular mechanisms of age-related bone loss. In: Rosen C, Glowacki J, Bilezikian JP (eds.) The Aging Skeleton. Academic Press, San Diego, CA, U.S.A., pp. 145-158.
45. Simonet WS, Lacey DL, Dunstan CR, et al. 1997 Osteoprotegerin: A novel secreted protein involved in the regulation of bone density [see comments]. Cell 89:309-319.
46. Yasuda H, Shima N, Nakagawa N, Mochizuki SI, Yano K, Fujise N, Sato Y, Goto M, Yamaguchi K, Kuriyama M, Kanno T, Murakami A, Tsuda E, Morinaga T, Higashio K 1998 Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139:1329-1337.
47. Demulder A, Takahashi S, Singer FR, Hosking DJ, Roodman GD 1993 Abnormalities in osteoclast precursors and marrow accessory cells in Paget's disease. Endocrinology 133:1978-1982.
48. Friedenstein AJ, Piatetzky S II, Petrakova KV 1966 Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morph 16:381-390.
49. Owen M 1970 The origin of bone cells. Int Rev Cytol 28:213-238.
50. Cody JD, Singer FR, Roodman GD, Otterund B, Lewis TB, Leppert M, Leach RJ 1997 Genetic linkage of Paget disease of the bone to chromosome 18q. Am J Hum Genet 61:1117-1122.
51. Haslam SI, Van Hul W, Morales-Piga A, Balemans W, San-Millan JL, Nakatsuka K, Willems P, Haltes NE, Ralston SH 1998 Paget's disease of bone: Evidence for a susceptibility locus on chromosome 18q and for genetic heterogeneity. J Bone Miner Res 13:911-917.
52. Hughes AE, Shearman AM, Weber JL, Barr RJ, Wallace RG, Osterberg PH, Nevin NC, Mollan RA 1994 Genetic linkage of familial expansile osteolysis to chromosome 18q. Hum Mol Genet 3:359-361.
53. Gordon MT, Cartwright EJ, Mercer S, Anderson DC, Sharpe PT 1994 HLA polymorphisms in Paget's disease of bone. Semin Arthritis Rheum 23:229.
54. Fraser WD 1997 Paget's disease of bone. Curr Opin Rheumatol 9:347-354.
55. Nellissery MJ, Padalecki SS, Brkanac Z, Singer FR, Roodman GD, Unni KK, Leach RJ, Hansen MF 1998 Evidence for a novel osteosarcoma tumor-suppressor gene in the chromosome 18 region genetically linked with Paget disease of bone. Am J Hum Genet 63:817-824.
56. Kuznetsov S, Gehron Robey P 1996 Species differences in growth requirements for bone marrow stromal fibroblast colony formation in vitro. Calcif Tissue Int 59:265-270.
57. Gehron Robey P 1992 Cell-mediated calcification in vitro. In: Bonucci E (ed.) Calcification in Biological Systems. CRC Press, Boca Raton, FL, U.S.A., pp. 107-127.
58. Ermolaeva OD, Sverdlov ED 1996 Subtractive hybridization, a technique for extraction of DNA sequences distinguishing two closely related genomes: Critical analysis. Genet Anal 13:49-58.
59. Schena M, Heller RA, Theriault TP, Konrad K, Lachenmeier E, Davis RW 1998 Microarrays: Biotechnology's discovery platform for functional genomics. Trends Biotechnol 16:301-306.
60. Bianco P, Robey PG 1999 Diseases of bone and the stromal cell lineage. J Bone Miner Res 14:336-341.
61. Ruddle NH, Li CB, Horne WC, Santiago P, Troiano N, Jay G, Horowitz M, Baron R 1993 Mice transgenic for HTLV-I LTR-tax exhibit tax expression in bone, skeletal alterations, and high bone turnover. Virology 197:196-204.
62. Grigoriadis AE, Schellander K, Wang ZQ, Wagner EF 1993 Osteoblasts are target cells for transformation in c-fos transgenic mice. J Cell Biol 122:685-701.
63. Krebsbach PH, Kuznetsov SA, Satomura K, Emmons RV, Rowe DW, Gehron Robey P 1997 Bone formation in vivo: Comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation 63:1059-1069.
64. Bianco P, Kuznetsov SA, Riminucci M, Fisher LW, Spiegel AM, Robey PG 1998 Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gs alpha-mutated skeletal progenitor cells. J Clin Invest 101:1737-1744.